Karyopharm Therapeutics
Price & Volume
Stats
See moreOpen | $5.60 |
Previous Close | $5.56 |
Day Range | $5.60-$5.67 |
52W Range | $3.51-$13.20 |
Market Cap | $94.8M |
Shares Short | 648,449 |
Financials
See moreRevenue (12 Mos) | $142.5M |
Revenue Growth (YoY) | 13.6% |
Gross Profit (12 Mos) | $148.7M |
Diluted EPS | -$14.70 |
News
See moreYahoo Finance • 19 days ago
Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immunotherapies | DelveInsight
Yahoo Finance • 2 months ago
Karyopharm rises on securing $100M in financing to extend cash runway into Q2 2026
Yahoo Finance • 3 months ago
Biotech Stocks Surge After Hours: CAPR, TMDX Lead Gains Amid Trial Updates And Earnings Momentum
Yahoo Finance • 3 months ago
Top movers analysis in the middle of the day on 2025-08-15: top gainers and losers in today's session.
About
CEO | Mr. Richard A. Paulson M.B.A. |
CFO | Ms. Lori A. Macomber CPA |
Address | 85 Wells Avenue, Newton, MA, United States, 02459-3298 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 279 |
